Autolus Therapeutics Ltd reported $-56.8M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AstraZeneca USD 5.16B 510M Jun/2026
Autolus Therapeutics Ltd USD -56.8M 13.28M Mar/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Novartis USD 6.48B 1.19B Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Silence Therapeutics USD -22.49M 69K Jun/2025